Organogenesis Holdings Inc’s recently made public that its 10% Owner ERANI ALBERT unloaded Company’s shares for reported $76875.0 on Jan 10 ’24. In the deal valued at $4.28 per share,17,972 shares were sold. As a result of this transaction, ERANI ALBERT now holds 59,007,134 shares worth roughly $156.96 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ERANI ALBERT sold 17,972 shares, generating $76,875 in total proceeds. Upon selling the shares at $4.28, the 10% Owner now owns 59,007,134 shares.
Before that, ERANI ALBERT sold 197,921 shares. Organogenesis Holdings Inc shares valued at $863,985 were divested by the 10% Owner at a price of $4.37 per share. As a result of the transaction, ERANI ALBERT now holds 59,025,106 shares, worth roughly $157.01 million.
Lake Street initiated its Organogenesis Holdings Inc [ORGO] rating to a Buy in a research note published on June 28, 2024; the price target was $5. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early February with a ‘”an Overweight”‘ rating. Morgan Stanley began covering ORGO with “an Equal-weight” recommendation on June 15, 2023. BTIG Research revised its rating on May 24, 2023. It rated ORGO as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ORGO
On Tuesday, Organogenesis Holdings Inc [NASDAQ:ORGO] saw its stock fall -1.48% to $2.66. Over the last five days, the stock has gained 6.40%. Organogenesis Holdings Inc shares have fallen nearly -34.96% since the year began. Nevertheless, the stocks have fallen -19.88% over the past one year. While a 52-week high of $4.70 was reached on 01/08/24, a 52-week low of $1.96 was recorded on 04/25/24. SMA at 50 days reached $2.63, while 200 days put it at $2.93. A total of 0.26 million shares were traded, compared to the trading of 1.09 million shares in the previous session.
Levels Of Support And Resistance For ORGO Stock
The 24-hour chart illustrates a support level at 2.62, which if violated will result in even more drops to 2.59. On the upside, there is a resistance level at 2.71. A further resistance level may holdings at 2.77. The Relative Strength Index (RSI) on the 14-day chart is 51.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.45%. Stochastics%K at 69.34% indicates the stock is a holding.
